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Objectives. The aim of this study was to investigate the inde-
pendent prognostic value of ischemic electrocardiographic (ECG)
findings for cardiovascular mortality and to evaluate a possible
sex-differential in this regard.
Background. In previous reports, ST segment and T wave
changes on the resting ECG were described as independent risk
factors for development of coronary heart disease. Although more
prevalent in women, they are often given less clinical importance
than in men.
Methods. Ten-year follow-up data from the Belgian Interuni-
versity Research on Nutrition and Health study were used. The
results presented here are based on ECGs of the 4,797 men and
4,320 women, aged 25 to 74 years, who were free of angina pectoris
at the start of follow-up, had no history of myocardial infarction
(MI) and showed no Q wave evidence of an old MI on their ECG.
Results. At baseline, the age-standardized prevalence of an
“ischemic ECG” (Minnesota codes I3, IV1–3, V1–3 or VII1) was
8.4% in men and 10.6% in women. Cardiovascular mortality rates
in men and women with an ischemic ECG were respectively 7.7
and 2.6 per 1,000 person-years, compared with 2.3 and 1.0 in those
with no such ECG findings. After correction for the potential
confounding effects of established cardiovascular disease (CVD)
risk factors, the multivariately adjusted risk ratios were 2.45 (95%
confidence interval [CI]: 1.70 to 3.53) for men and 2.16 (95% CI:
1.30 to 3.58) for women. Testing the interaction between an
ischemic ECG and sex on CVD mortality revealed that the risk
ratios were not significantly changed (p 5 0.95). The etiologic
fraction of CVD deaths attributable to an ischemic ECG was
estimated as 19.3% for men and 22.4% for women. Both men and
women with major ischemic findings in their baseline electrocar-
diogram (Minnesota codes IV1,2, V1,2 or VII1) had a fourfold
increased risk of CVD death.
Conclusion. These results support the hypothesis that women
with ischemic ECG findings are at the same increased risk for
CVD mortality as men.
(J Am Coll Cardiol 1998;32:680–5)
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Gender differences in diagnosis, treatment and prognosis of
cardiovascular disease (CVD) has received increasing atten-
tion in preventive cardiology. This study focuses on gender
differences in the prognostic value for CVD mortality of
repolarization abnormalities considered to represent various
degrees of myocardial ischemia.
Because of important differences in CVD mortality and
morbidity rates between the sexes, epidemiologic studies have
dealt with the potential sex differential in certain CVD risk
factors and their impact. For instance, it is documented that
serum triglycerides have greater predictive value for coronary
heart disease (CHD) in women compared to men (1). One of
the established risk factors for CVD, ST-T abnormalities on
the resting electrocardiogram (ECG), is independently associ-
ated with subsequent development of CHD (2–11). Most of the
studies, however, were carried out in men and cohort studies
on this issue in women are rare. Nevertheless, in clinical
practice the presence of ST-T findings is given less weight in
women despite their higher prevalences.
The aims of our study were 1) to study the independent
prognostic value of ischemic ECG findings for CVD mortality
in men and women free of CHD at baseline and 2) to study
whether there is a gender difference in this prognostic value.
Methods
Study population. The results are based on observations
made in the men and women who took part in the Belgian
Interuniversity Research on Nutrition and Health (BIRNH)
study. This study, in which baseline measurements were made
in the years 1981 to 1984, focuses on the distribution of
cardiovascular risk factors and nutritional habits in Belgium
and their relation to total and cause-specific mortality. The
detailed methodology and results were published elsewhere
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(12,13). An age- and sex-stratified population sample of sub-
jects 25 to 74 years old was selected at random from 42 of the
43 Belgian geographic districts. To achieve a sufficient sample
size under circumstances in which little pressure was put on
invited eligible subjects, a sample of more than 30,000 persons
was selected. The participation rate was 36.5%, resulting in
11,302 subjects taking part in the study (5,949 men and 5,353
women). A 10% random sample of the nonparticipants was
selected and invited to answer a number of questions related to
smoking and nutritional habits, which revealed that no differ-
ences exist between participants and nonparticipants with
respect to lifestyle (13). It was not feasible, however, to
compare participants and nonparticipants with regard to their
ECG pattern.
Data used in the present analysis are those from the 4,797
men and 4,320 women free of prevalent CHD at baseline,
defined as being free of angina pectoris or a positive history of
acute myocardial infarction according to the Rose question-
naire (14), and having no Q wave evidence of an old myocar-
dial infarction on their resting ECG at baseline (Q and QS
patterns, Minnesota coding criteria I1,2).
The study design and methodology was approved by the
ethical committees of the University of Ghent and the Free
University of Brussels.
Follow-up. The global sample was followed for at least 10
years for cause-specific mortality, the follow-up being complete
in 99% of the participants. Vital status was checked through
local community registers and causes of death were ascer-
tained from the family doctor and/or the doctor who com-
pleted the death certificate. Where appropriate, more infor-
mation on the exact cause of death was collected from hospital
or medical records. According to the International Classifica-
tion of Diseases (ICD) (15), we considered as cause of death
from CVD all codes ranging from 390 to 459. Cases of CHD
mortality were defined as those with ICD-codes 410 to 414.
After 10 years, 144 men and 67 women were identified as CVD
deaths; 66 men and 27 women died from CHD.
Resting ECG. Using a 3-channel Hewlett-Packard device
type 1516B, a 12-lead ECG lasting, on average, 16 s, was
taken in supine position in accordance with classical recom-
mendations. All tracings were coded by a trained physician
on the basis of Minnesota criteria (16). Signs of an ischemic
ECG were defined as the presence of either a borderline Q
wave (code I3), significant or borderline ST-segment depres-
sion (codes IV1–3), deep or moderate T-wave inversion
(codes V1–3) or evidence of complete left bundle branch
block (code VII1). These ischemic ECG findings were
further categorized in major and minor ischemic abnormal-
ities; major ECG ischemia was defined as the presence of
Minnesota codes IV1,2, V1,2 and VII1, minor ECG ischemia
either a code I3, IV3 or V3.
Covariates. Clinical and biochemical measurements were
made on all participating subjects using standardized and
validated methods. Blood pressure was determined using a
random sphygmomanometer, and a nonfasting blood sample
was taken from an antecubital vein in supine position and
analyzed in a central laboratory for serum total cholesterol and
serum uric acid concentrations. Information on smoking be-
havior, history of diabetes mellitus and current antihyperten-
sive drug treatment was obtained by questionnaire. The body
mass index (BMI) was calculated as weight (kg) divided by
height squared (m2). Left ventricular hypertrophy, defined as
isolated hypertrophy (Minnesota code III1), was included as an
additional confounding factor as it was twice more prevalent in
subjects with an ischemic ECG.
Statistical methods. Age-standardized cardiovascular mor-
tality rates were obtained using the method of direct standard-
ization using 10-year age-strata with the male and female
sample of subjects with no ECG ischemia as reference (17).
Statistical analysis of the association between ischemic ECG
findings and CVD mortality was performed by fitting Cox
proportional hazard models (18) with additional covariates of
age (years), BMI (kg/m2), current smoking (yes/no), systolic
blood pressure (mm Hg), total serum cholesterol (mg/dl), uric
acid (mg/dl), diabetic status (yes/no) and antihypertensive drug
use (yes/no). The statistical significance of a variable in the
model was determined according to the Wald chi-square
statistic. Statistical interaction between ECG findings and
gender was evaluated by fitting their multiplicative effect. All
models were checked on the assumption of proportionality of
hazards. The global level for statistical significance was taken
as alpha 5 0.05 and all analyses were performed using SAS
software (SAS System for Windows, Release 6.11, SAS Insti-
tute Inc., Cary, NC.) The proportion of CVD deaths in the
global sample that could be attributed to the presence of an
ischemic ECG is expressed as the population etiologic fraction
PE(RR-1)/RR), where RR is the risk ratio and PE the propor-
tion of deceased subjects that had a baseline ischemic ECG
(17).
Results
In Figure 1 the prevalences of an ischemic ECG finding are
shown stratified by age group and gender. As expected, these
prevalences are clearly age-related, giving subjects in the
highest age group a tenfold higher prevalence than the young-
est individuals in the sample. The overall age-standardized
prevalence of an ischemic ECG was 8.4% in men and 10.6% in
women. This higher prevalence in women was consistently
observed in all age groups. Differences between sexes were not
Abbreviations and Acronyms
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present, however, for so-called major ischemic abnormalities
(codes IV1,2, V1,2 and VII1) with age-standardized prevalences
of, respectively, 1.9% in men and 1.8% in women (age-specific
prevalences shown in Fig. 1 as the horizontal line within bars).
Consequently, the gender difference in prevalence of ischemic
ECG findings was largely due to differences in the occurrence
of Minnesota codes IV3 and V3, both known to be more
prevalent in women.
Table 1 shows that ischemic ECG findings are mainly
negative T-waves (code V1–3) either occurring alone or in
conjunction with ST-segment depressions (code IV1–3). The
latter are found relatively more often in women, while border-
line Q wave patterns (code I3) and left bundle branch blocks
(code VII1) are more often observed among men. Isolated
ST-segment depression was found only in one man.
Figure 2 shows the estimated actuarial survival curves by
gender and presence of ischemic signs on the baseline ECG.
As expected, CVD mortality is much higher in men compared
to women but an ischemic ECG at baseline increases the risk
of cardiovascular death in both sexes. In our sample, cumula-
tive mortality in men with an initial ischemic ECG was about
14% after 10 years. The form of these curves also suggests that
the effect of ischemia on the baseline ECG on CVD mortality
is not specifically short- or long-term but is rather constant
over the whole follow-up period. Even after a longer period,
subjects showing signs of ischemia on their initial ECG are
dying faster from CVD than those with no ischemic ECG.
The age-standardized CVD mortality rates experienced
over the whole follow-up period are 7.65 and 2.56 per 1,000
person-years in men and women having ischemic ECG findings
(Table 2). For the men and women not showing signs of
ischemia on their ECG at the start of the follow-up period, the
mortality rates are, respectively, 2.28 and 1.02 per 1,000
person-years. For the major ST-T findings, CVD mortality is
about eightfold higher in men and sixfold higher in women,
with age-adjusted mortality rates of 18.00 and 5.86 per 1,000
person-years in men and women, respectively.
According to Cox regression analyses shown in Table 3, the
multivariately adjusted RR related to an initial ischemic ECG
are 2.16 in women and 2.45 in men, both RR being significantly
different from one, concluded from their 95% confidence
intervals (CI). Modeling the multiplicative effect in a Cox
model between gender and presence of a baseline ischemic
ECG revealed no interaction between these variables (p 5
0.95); hence, both RR were not significantly different. In our
sample, a sex differential of ischemic ECG findings in predict-
ing CVD mortality could not be demonstrated. We reached the
Figure 2. Estimated actuarial survival curves according to baseline
ischemic ECG abnormalities in both sexes from the BIRNH study.
Table 1. Composition of Ischemic ECG Findings in Men
and Women
Minnesota Code Men Women
Code I3 only 69 (17.1%) 45 (9.8%)
Code IV1–3 only 1 (0.3%) 0 (0%)
Code V1–3 only 216 (53.5%) 277 (60.5%)
Code VII1 only 28 (6.9%) 15 (3.3%)
Codes I3 and V1–3 combined 4 (1.0%) 12 (2.6%)
Codes I3 and IV1–3 combined 1 (0.3%) 0 (0%)
Codes IV1–3 and V1–3 combined 77 (19.1%) 103 (22.5%)
Codes I3 and IV1–3 and V1–3 combined 8 (2.0%) 6 (1.3%)
Ischemic ECG 404 (100%) 458 (100%)
ECG 5 electrocardiographic; I 5 Q waves; IV 5 ST segments; V 5 negative
T waves.
Figure 1. Prevalences of ischemic ECG abnormalities by age and
gender from the BIRNH study.
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same conclusion comparing the etiologic fractions related to
an ischemic ECG. The proportion of CVD deaths attributed to
ECG ischemia is 19.3% in men and 22.4% in women.
In our multivariate analysis, ischemic ECG findings at
baseline were among the strongest predictors for cardiovascu-
lar mortality. In both men and women only the effect of age
was more pronounced, contrasted with the effect of other
classical CVD risk factors such as systolic blood pressure,
smoking, BMI and total cholesterol. Entering minor and major
ischemic ECG findings simultaneously in a multivariate model
with adjustment for the other risk factors revealed again a
similarity of RR between genders. Men and women with major
ischemic-like changes on their baseline ECG had a more than
fourfold risk of CVD death. The risk for those subjects with
minor ischemic ECG findings was much less and in both sexes
failed to reach statistical significance at the 5% level.
In an extra analysis with exclusion of persons with ECG
codes I3 and VII1, we performed a Cox regression analysis
relating combined ST-T changes and isolated T wave abnor-
malities to later CVD mortality. Interaction testing failed to
detect a sex differential for both these ECG classifications. The
result of this analysis, pooling men and women, was that
combined ST-T changes were most predictive with a multivar-
iate RR of 5.11 (95% CI: 3.40 to 7.68), while the independent
prognostic value of isolated T wave abnormalities was much
less pronounced and only of borderline significance (RR 5
1.49 [95% CI: 0.95 to 2.31]).
CHD mortality. In men, 45.8% of all CVD deaths were
labeled as CHD deaths while for women this proportion was
40.3%. Modeling the association between all ischemic ECG
changes and CHD mortality, adjusting for the same list of
covariates, showed again the similarity of the impact of an
ischemic ECG on CHD death for men and women. The
adjusted RR for men was 2.03 (95% CI: 1.15 to 3.56) while for
women it was 2.15 (95% CI: 0.96 to 4.84). The interaction term
between gender and initial ischemic ECG changes was once
more not statistically significant (p 5 0.52). Mortality rates
after 10 years were too low to perform a powerful analysis of
the relation between major ischemic ECG changes and CHD
death.
Table 2. Age-Specific Number of CVD Deaths and Age-Standardized CVD Mortality Rates in Subgroups According to Ischemic ECG
Findings in Men and Women
Age Group
CVD Death
Rate†25–34 yr 35–44 yr 45–54 yr 55–64 yr 65–74 yr
Men
No ischemic ECG changes 0/917 (9,203)* 4/1,083 (10,846) 8/978 (9,599) 37/870 (8,227) 48/545 (4,736) 2.28
Ischemic ECG changes 0/21 (212) 0/42 (407) 9/85 (786) 15/125 (1,085) 23/131 (1,067) 7.65
Major ischemic ECG changes 0/2 (20) 0/6 (61) 3/16 (134) 10/30 (205) 10/39 (315) 18.00
Minor ischemic ECG changes‡ 0/19 (192) 0/38 (367) 7/75 (705) 6/102 (942) 16/105 (863) 5.09
Women
No ischemic ECG changes 0/818 (8,225) 1/1,017 (10,236) 2/931 (9,288) 18/712 (7,018) 18/384 (3,588) 1.02
Ischemic ECG changes 0/23 (232) 0/54 (540) 1/102 (1,005) 6/139 (1,357) 21/140 (1,302) 2.56
Major ischemic ECG changes 0/1 (10) 0/5 (50) 0/14 (141) 3/27 (255) 10/30 (252) 5.86
Minor ischemic ECG changes‡ 0/22 (222) 0/52 (520) 1/92 (905) 5/122 (1,194) 14/121 (1,143) 1.76
CVD 5 cardiovascular disease; ECG 5 electrocardiographic. *Cell entries are number of CVD deaths over the number of subjects in that cell at the start of the
follow-up period (number of person-years are given between parentheses). †Age-standardized mortality rates per 1,000 person-years. ‡Subjects with major ischemic
ECG abnormalities excluded.
Table 3. Adjusted Risk Ratios (195% CI) for CVD Mortality According to Ischemic ECG Findings in
Both Men and Women
Men Women
RR 95% CI RR 95% CI
Age-adjusted
Ischemic ECG changes 2.83 (1.98–4.03) 2.44 (1.49–4.01)
Minor ischemic ECG changes* 1.43 (0.93–2.18) 1.48 (0.87–2.52)
Major ischemic ECG changes† 4.55 (2.85–7.27) 5.09 (2.74–9.44)
Multivariately adjusted‡
Ischemic ECG changes 2.45 (1.70–3.53) 2.16 (1.30–3.58)
Minor ischemic ECG changes* 1.26 (0.82–1.93) 1.46 (0.85–2.52)
Major ischemic ECG changes† 4.21 (2.60–6.82) 4.72 (2.49–8.96)
CI 5 confidence interval; CVD 5 cardiovascular disease; ECG 5 electrocardiographic; RR 5 risk ratio. *Additional
adjustment for major ischemic ECG changes. †Additional adjustment for minor ischemic ECG changes. ‡Adjustment for
age, body mass index, systolic blood pressure, total cholesterol, smoking, uric acid, diabetes, left ventricular hypertrophy
and use of antihypertensive drugs.
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Discussion
Ischemic ECG changes and CVD: Reported results. In the
epidemiologic literature many studies deal with the prognostic
value of ECG ST-T changes for CVD or CHD mortality.
However, until more recently most of these studies have
concentrated on men (2,3). According to 5-year follow-up data
of 5,738 men aged 30 to 59 years, Reunanen et al. (4) reported
in one of the earlier studies that subjects with a baseline
Minnesota code IV1–3 or V1,2 had about five times more risk of
dying from CHD. In a more recent study (10) from data in
9,139 men aged 40 to 80 years without CHD at baseline taking
part in the Reykjavik study and followed-up for up to 24 years,
an adjusted relative risk of 2 was found for CHD in subjects
with silent ST-T changes on their initial ECG. Schouten et al.
(9) reported on a Dutch study of 1,583 men aged 40 to 65 years
in which after a 15-year follow-up, CVD mortality rates were
elevated by 90% (RR 5 1.9) in those with ST-segment
depression greater than 0.25 mm.
In one of the earliest reports on signs of ischemia on the
ECG among women as well as men, Liao et al. (6) looked in
more detail at sex differences in the relationship of ECG ST-T
findings to risk of CHD based on data from the Chicago Heart
Association Detection Project in Industry. In the 9,203 men
and 7,818 women, aged 40 to 64 years and free of CHD at
baseline, the age-standardized prevalences of ST-T changes
were 8.1% in men and 12.3% in women. Based on these
baseline observations and after a follow-up period of 11.5
years, they found a relative risk for CHD mortality of 2.6 (p ,
0.0001) in men and 1.4 in women (not significant). In their
multivariate analysis, the sex difference in risk ratios turned out
to be at borderline significance (p 5 0.09). Nevertheless, the
authors concluded that with the use of the same criteria for
ST-segment depression and T wave abnormality for both sexes,
it may be that more women than men are misclassified as
abnormal. They considered whether it might be appropriate to
use different criteria for ST-T abnormalities for the two sexes.
In contrast to their findings, several other studies found that
having an initial ischemic ECG carries the same prognostic
value for CVD or CHD in men and women. In the Busselton
study (8), for example, the age-standardized relative risks for
CVD mortality in subjects aged 40 to 79 years after a follow-up
period of 13 years, were 2.1 and 2.2 for men and women having
a code IV2 abnormality on their baseline ECG and 3.5 and 5.2
for those with a code V2. Also for less pronounced T wave
abnormalities (code V3), women had a higher relative risk for
CVD mortality than men (3.0 vs. 2.3). Because of the limited
sample size (1,056 men, 1,063 women), a powerful analysis of
the predictive value of other specific ST-T changes proved
impossible. Similar results were obtained by Kannel et al. (5) in
their analysis of the 30-year follow-up data in the Framingham
study. They report that nonspecific ST-T abnormalities (ST-
segment depression .1 mm and/or T wave flattening or
inversion) have a higher prognostic value for CHD in women
compared to men, after adjustment for age, systolic blood
pressure and total cholesterol (relative risks of 1.3 in middle-
aged men and 1.6 in middle-aged women). In the Renfrew and
Paisley Survey (11), relative risks for ischemic heart disease
mortality related to ECG “evidence of ischemia” at baseline
(Minnesota codes I1–3, IV1–4, V1–3 and VII1) were also com-
parable between sexes. The RR, obtained after a 15-year
follow-up of 7,058 men and 8,353 women aged 45 to 64 years
(adjusted for age, diastolic blood pressure, total cholesterol
and smoking), were 2.5 in men and 2.3 in women, both RR
being significantly different from one but not from each other.
Definition of ischemic ECG changes and statistical power.
The definition of ischemic findings as used in this study may
seem arbitrary although comparable to those adopted in the
studies mentioned earlier, as it includes less meaningful codes
which we grouped separately as “minor” ischemic abnormali-
ties. In our study, these so-called minor ECG changes are
indeed shown to be of lesser importance for future cardiovas-
cular mortality. The association between major ischemic ECG
stigmata and CVD mortality is strong. The association between
major ischemic changes and CHD mortality was not studied in
detail due to the insufficient number of CHD and natural
deaths. To consider the second main objective of our study (no
sex-differential in predictive value) with sufficient statistical
power, we used the broader definition of ECG ischemia and
concentrated mainly on cardiovascular mortality rather than
CHD mortality. So, to gain sensitivity (statistical power), some
specificity of the issue was given up. In the group with a normal
ECG the sex ratio in age-standardized CVD mortality rates
was about 2.5, which is in line with what is known from
mortality statistics in Belgium. Power calculations based on the
number of CVD deaths as observed over the complete
follow-up period showed that the likelihood of detecting a true
similar sex effect (RR 5 2.5) in CVD mortality risk in the
group of individuals with a baseline ischemic ECG was 82%.
Specificity of the impact of ischemic ST-T changes. The
question arises whether the association is confounded by the
presence of other abnormalities on the initial ECG. In our data
set, ischemic ECG changes were significantly associated only
with arrhythmias (Minnesota code VIII1– 6) in men and
women. However, adding the presence of arrhythmias on the
baseline ECG as a covariate in our multivariate model did not
change the estimated RR.
Apart from borderline Q wave and left bundle branch block
(codes I3 and VII1), about one third of the ischemic findings in
our study were combined ST-segment and T wave abnormali-
ties and two thirds were isolated T wave changes. These two
categories may carry a different meaning in relation to isch-
emia, and also their risk may substantially differ. In an extra
analysis with exclusion of subjects with borderline Q wave
changes or left bundle branch block, we observed strongly
elevated CVD death rates in the group with combined ST-T
changes compared to the rather moderate risk in subjects
showing T wave changes only on their baseline ECG.
Selection bias and external validity. The BIRNH study is
not characterized by a high participation rate and hence could
be subject to selection bias. However, analysis of a 10%
nonrespondent sample revealed no major differences in
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lifestyle-related characteristics between participants and non-
participants. Another argument favoring acceptable external
validity for our study can be found in the mortality experience
over the 10 years of follow-up. The age- and sex-specific total
mortality rates for the BIRNH participants were very compa-
rable to the estimates from official age- and sex-specific
national mortality statistics in Belgium.
Conclusions. In conclusion, the results from our study
indicate that, first, in subjects clinically free of CHD, the
prevalence of ischemic ECG findings is higher in women than
in men over all age groups. Second, a baseline ischemic ECG
is associated in both sexes with a higher risk for CVD mortality
independent of other classical risk factors, this effect being not
specifically short- or long-term. And finally, this prognostic
value is comparable between the sexes. From this we conclude
that the clinical judgment of major ischemic findings on the
resting ECG should not be different for men and women.
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